-
Lawyer for pharma company argues against single trial in B.C. opioid damages case
Gordon McKee, a lawyer for Janssen Inc. and Johnson & Johnson, told the B.C. Supreme Court that certifying Canadian governments as a class in their pursuit of damages against opioid makers isn’t manageable or preferable compared with separate trials. -
Year-end tax-loss selling for your pharmacy business
Tax-loss selling is an investment strategy that can lower your tax bill. Interested in knowing more? Does this apply to your pharmacy business? Read on. This investment strategy kicks in when you sell a stock for a capital loss, so that you can use the loss to offset realized capital gains with a view to reducing the tax you ultimately pay.